Egetis Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Egetis Therapeutics has a total shareholder equity of SEK545.6M and total debt of SEK108.6M, which brings its debt-to-equity ratio to 19.9%. Its total assets and total liabilities are SEK760.2M and SEK214.6M respectively.
Key information
19.9%
Debt to equity ratio
kr108.60m
Debt
| Interest coverage ratio | n/a |
| Cash | kr303.30m |
| Equity | kr545.60m |
| Total liabilities | kr214.60m |
| Total assets | kr760.20m |
Recent financial health updates
Here's Why We're Not Too Worried About Egetis Therapeutics' (STO:EGTX) Cash Burn Situation
May 26
We're Keeping An Eye On Egetis Therapeutics' (STO:EGTX) Cash Burn Rate
Dec 21Will Egetis Therapeutics (STO:EGTX) Spend Its Cash Wisely?
Jun 07Recent updates
Here's Why We're Not Too Worried About Egetis Therapeutics' (STO:EGTX) Cash Burn Situation
May 26We're Keeping An Eye On Egetis Therapeutics' (STO:EGTX) Cash Burn Rate
Dec 21Will Egetis Therapeutics (STO:EGTX) Spend Its Cash Wisely?
Jun 07Is Egetis Therapeutics AB (publ) (STO:EGTX) Trading At A 30% Discount?
Jan 19Egetis Therapeutics AB (publ) (STO:EGTX) Is Expected To Breakeven In The Near Future
Mar 22What Type Of Returns Would Egetis Therapeutics'(STO:EGTX) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Feb 15What You Need To Know About Egetis Therapeutics AB (publ)'s (STO:EGTX) Investor Composition
Jan 20
Egetis Therapeutics AB (publ) (STO:EGTX) Insiders Increased Their Holdings
Dec 24Analyst Forecasts For PledPharma AB (publ) (STO:PLED) Are Surging Higher
Dec 03When Will PledPharma AB (publ) (STO:PLED) Breakeven?
Dec 03Financial Position Analysis
Short Term Liabilities: EGTX's short term assets (SEK345.9M) exceed its short term liabilities (SEK103.9M).
Long Term Liabilities: EGTX's short term assets (SEK345.9M) exceed its long term liabilities (SEK110.7M).
Debt to Equity History and Analysis
Debt Level: EGTX has more cash than its total debt.
Reducing Debt: EGTX's debt to equity ratio has increased from 0% to 19.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EGTX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: EGTX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 22.6% each year